# NR3C1

## Overview
The NR3C1 gene encodes the nuclear receptor subfamily 3 group C member 1, commonly known as the glucocorticoid receptor (GR), which is a pivotal component of the nuclear hormone receptor super-family. This receptor is integral to the regulation of gene expression in response to glucocorticoids, a class of steroid hormones that influence a wide array of physiological processes, including metabolism, immune response, and stress adaptation. The GR functions primarily as a transcription factor, modulating the transcription of target genes upon binding with glucocorticoid hormones. Structurally, the receptor comprises several domains, including a DNA-binding domain, a ligand-binding domain, and a transactivation domain, which are essential for its interaction with DNA and other proteins. The NR3C1 gene is subject to alternative splicing, resulting in multiple isoforms that can have distinct functional roles depending on the tissue context (Bray2003Variations; Nunez2002Characterization; Giguère1986Functional).

## Structure
The NR3C1 gene encodes the glucocorticoid receptor, a protein that plays a crucial role in regulating gene expression in response to glucocorticoids. The primary structure of the glucocorticoid receptor includes a DNA-binding domain characterized by zinc finger motifs, a ligand-binding domain, and a transactivation domain. These domains are essential for the receptor's function in binding to DNA and interacting with glucocorticoids (Nunez2002Characterization).

The secondary structure of the glucocorticoid receptor features alpha helices and beta sheets, which contribute to the protein's stability and function. The tertiary structure involves the folding of these secondary elements into a functional conformation, allowing the receptor to interact with other molecules and perform its regulatory roles. The quaternary structure may involve dimerization, which is important for the receptor's activity as a transcription factor (Nunez2002Characterization).

Post-translational modifications such as phosphorylation and acetylation are common in the glucocorticoid receptor, influencing its activity and stability. The NR3C1 gene also produces multiple splice variant isoforms, which can result in different functional outcomes depending on the tissue-specific expression patterns (Turner2005Structure; Breslin2001Multiple).

## Function
The NR3C1 gene encodes the glucocorticoid receptor (GR), a critical component of the nuclear hormone receptor super-family. This receptor plays a vital role in the body's response to glucocorticoids, which are steroid hormones involved in regulating various physiological processes such as metabolism, immune response, and stress adaptation (ZHOU2005The; Bray2003Variations). The GR is primarily active in the cytoplasm and nucleus of cells, where it functions as a transcription factor. Upon binding with glucocorticoid hormones, the receptor translocates to the nucleus and binds to glucocorticoid response elements in DNA, modulating the transcription of target genes (Bray2003Variations; Giguère1986Functional).

The GR protein consists of several functional domains, including the N-terminal modulatory domain, the central DNA-binding domain, and the C-terminal ligand-binding domain. These domains are essential for the receptor's ability to regulate gene expression, interact with heat-shock proteins, and undergo allosteric transformations necessary for its function (ZHOU2005The; Bray2003Variations). The receptor's activity influences a wide range of cellular activities and organismal outcomes, such as controlling inflammation and maintaining energy balance (Niu2009Human).

## Clinical Significance
Mutations and alterations in the NR3C1 gene, which encodes the glucocorticoid receptor, are associated with several clinical conditions. In acute lymphoblastic leukemia (ALL), NR3C1 mutations such as p.R477H, p.Y478C, p.P530fs, and p.H726P lead to glucocorticoid resistance, a significant challenge in treatment due to the role of glucocorticoids in therapy. These mutations result in the loss of transcriptional activity in response to glucocorticoids like dexamethasone, contributing to treatment failure and relapse in ALL patients (Liu2021Association).

In blastic plasmacytoid dendritic cell neoplasm (BPDCN), NR3C1 haploinsufficiency is linked to corticoresistance and poor survival outcomes. This condition is characterized by reduced glucocorticoid receptor expression, which may lead to resistance to glucocorticoid-induced apoptosis (Emadali2016Haploinsufficiency).

Familial or Sporadic Primary Generalized Glucocorticoid Resistance, also known as Chrousos syndrome, is another condition associated with NR3C1 mutations. This syndrome is marked by decreased sensitivity to glucocorticoids, leading to compensatory elevations in ACTH and cortisol, which can cause bilateral adrenal hyperplasia and mineralocorticoid excess (Nicolaides2018Bilateral).

These findings underscore the critical role of NR3C1 in mediating glucocorticoid response and its implications in various diseases.

## Interactions
The NR3C1 gene encodes the glucocorticoid receptor (GR), which is involved in various protein interactions essential for its function. GR forms heterocomplexes with heat shock proteins, particularly hsp90 and hsp70, which are crucial for its activation and steroid-binding state. This assembly involves a multiprotein complex, including p60 and p23, and is ATP-dependent. The presence of p23 is vital for stabilizing the complex, and the antibiotic geldanamycin can disrupt this assembly by binding to hsp90, blocking p23 binding (Pratt1997Steroid).

GR also interacts with immunophilins such as FKBP52, which is part of the GR-hsp90 heterocomplex. FKBP52 is involved in the nuclear targeting of the receptor, suggesting a role in receptor trafficking (Pratt1997Steroid). Additionally, GR interacts with c-Jun and c-Fos, where mutual inhibition of DNA binding occurs due to direct protein-protein interactions. This interaction is specific to the DNA binding domains of both GR and c-Jun, with the 'leucine zipper' region of c-Jun being a potential site for this interaction (YangYen1990Transcriptional).

These interactions highlight the complex network of protein associations that regulate the function and activity of the glucocorticoid receptor.


## References


[1. (Pratt1997Steroid) William B. Pratt and David O. Toft. Steroid receptor interactions with heat shock protein and immunophilin chaperones*. Endocrine Reviews, 18(3):306–360, June 1997. URL: http://dx.doi.org/10.1210/edrv.18.3.0303, doi:10.1210/edrv.18.3.0303. This article has 112 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1210/edrv.18.3.0303)

[2. (Emadali2016Haploinsufficiency) Anouk Emadali, Neda Hoghoughi, Samuel Duley, Azadeh Hajmirza, Els Verhoeyen, Francois-Loic Cosset, Philippe Bertrand, Christophe Roumier, Anne Roggy, Céline Suchaud-Martin, Martine Chauvet, Sarah Bertrand, Sieme Hamaidia, Sophie Rousseaux, Véronique Josserand, Julie Charles, Isabelle Templier, Takahiro Maeda, Juliana Bruder-Costa, Laurence Chaperot, Joel Plumas, Marie-Christine Jacob, Thierry Bonnefoix, Sophie Park, Remy Gressin, Cornelis P. Tensen, Cristina Mecucci, Elizabeth Macintyre, Dominique Leroux, Elisabeth Brambilla, Florence Nguyen-Khac, Isabelle Luquet, Dominique Penther, Christian Bastard, Fabrice Jardin, Christine Lefebvre, Francine Garnache, and Mary B. Callanan. Haploinsufficiency for nr3c1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms. Blood, 127(24):3040–3053, June 2016. URL: http://dx.doi.org/10.1182/blood-2015-09-671040, doi:10.1182/blood-2015-09-671040. This article has 59 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2015-09-671040)

[3. (Breslin2001Multiple) Mary B. Breslin, Chuan-Dong Geng, and Wayne V. Vedeckis. Multiple promoters exist in the human gr gene, one of which is activated by glucocorticoids. Molecular Endocrinology, 15(8):1381–1395, August 2001. URL: http://dx.doi.org/10.1210/mend.15.8.0696, doi:10.1210/mend.15.8.0696. This article has 86 citations.](https://doi.org/10.1210/mend.15.8.0696)

[4. (Turner2005Structure) Jonathan D Turner and Claude P Muller. Structure of the glucocorticoid receptor (nr3c1) gene 5′ untranslated region: identification, and tissue distribution of multiple new human exon 1. Journal of Molecular Endocrinology, 35(2):283–292, October 2005. URL: http://dx.doi.org/10.1677/jme.1.01822, doi:10.1677/jme.1.01822. This article has 206 citations and is from a peer-reviewed journal.](https://doi.org/10.1677/jme.1.01822)

[5. (ZHOU2005The) J ZHOU and J CIDLOWSKI. The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids, 70(5–7):407–417, May 2005. URL: http://dx.doi.org/10.1016/j.steroids.2005.02.006, doi:10.1016/j.steroids.2005.02.006. This article has 274 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.steroids.2005.02.006)

[6. (Nunez2002Characterization) B.Scott Nunez and Wayne V. Vedeckis. Characterization of promoter 1b in the human glucocorticoid receptor gene. Molecular and Cellular Endocrinology, 189(1–2):191–199, March 2002. URL: http://dx.doi.org/10.1016/s0303-7207(01)00676-1, doi:10.1016/s0303-7207(01)00676-1. This article has 43 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0303-7207(01)00676-1)

[7. (Niu2009Human) Nifang Niu, Venkatraman Manickam, Krishna R. Kalari, Irene Moon, Linda L. Pelleymounter, Bruce W. Eckloff, Eric D. Wieben, Daniel J. Schaid, and Liewei Wang. Human glucocorticoid receptor α gene (nr3c1) pharmacogenomics: gene resequencing and functional genomics. The Journal of Clinical Endocrinology &amp; Metabolism, 94(8):3072–3084, August 2009. URL: http://dx.doi.org/10.1210/jc.2008-2109, doi:10.1210/jc.2008-2109. This article has 32 citations.](https://doi.org/10.1210/jc.2008-2109)

[8. (Nicolaides2018Bilateral) Nicolas C Nicolaides and George P Chrousos. Bilateral adrenal incidentalomas and nr3c1 mutations causing glucocorticoid resistance: is there an association? European Journal of Endocrinology, 179(5):C1–C4, November 2018. URL: http://dx.doi.org/10.1530/eje-18-0471, doi:10.1530/eje-18-0471. This article has 8 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1530/eje-18-0471)

[9. (Bray2003Variations) Paula J. Bray and Richard G.H. Cotton. Variations of the human glucocorticoid receptor gene (nr3c1): pathological and in vitro mutations and polymorphisms. Human Mutation, 21(6):557–568, May 2003. URL: http://dx.doi.org/10.1002/humu.10213, doi:10.1002/humu.10213. This article has 109 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.10213)

[10. (YangYen1990Transcriptional) Hsin-Fang Yang-Yen, Jean-Claude Chambard, Yu-Lin Sun, Tod Smeal, Thomas J. Schmidt, Jacques Drouin, and Michael Karin. Transcriptional interference between c-jun and the glucocorticoid receptor: mutual inhibition of dna binding due to direct protein-protein interaction. Cell, 62(6):1205–1215, September 1990. URL: http://dx.doi.org/10.1016/0092-8674(90)90396-v, doi:10.1016/0092-8674(90)90396-v. This article has 1125 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/0092-8674(90)90396-v)

[11. (Liu2021Association) Haiyan Liu, Ziping Li, Fei Qiu, Chunjie Li, Xiaojing Lin, Yingyi He, Maoxiang Qian, Yuanbin Song, and Hui Zhang. Association between nr3c1 mutations and glucocorticoid resistance in children with acute lymphoblastic leukemia. Frontiers in Pharmacology, March 2021. URL: http://dx.doi.org/10.3389/fphar.2021.634956, doi:10.3389/fphar.2021.634956. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphar.2021.634956)

[12. (Giguère1986Functional) Vincent Giguère, Stanley M. Hollenberg, Michael G. Rosenfeld, and Ronald M. Evans. Functional domains of the human glucocorticoid receptor. Cell, 46(5):645–652, August 1986. URL: http://dx.doi.org/10.1016/0092-8674(86)90339-9, doi:10.1016/0092-8674(86)90339-9. This article has 626 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/0092-8674(86)90339-9)